Cornerstone Capital Management Holdings’s MacroGenics MGNX Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$475K	Sell	25,038 -8,400	-25%	-$157K	﹤0.01%	1016
2017 Q3	$617K	Buy	33,438 +10,200	+44%	+$177K	﹤0.01%	1016
2017 Q2	$406K	Buy	23,238 +848	+4%	+$16.2K	﹤0.01%	1066
2017 Q1	$416K	Sell	22,390 -810	-3%	-$15.6K	﹤0.01%	1086
2016 Q4	$473K	Sell	23,200 -29,000	-56%	-$730K	﹤0.01%	1102
2016 Q3	$1.56M	Buy	52,200 +45,600	+691%	+$1.36M	0.01%	842
2016 Q2	$178K	Sell	6,600 -65,643	-91%	-$1.48M	﹤0.01%	1211
2016 Q1	$1.35M	Buy	72,243 +27,500	+61%	+$524K	0.01%	848
2015 Q4	$1.39M	Buy	44,743 +20,929	+88%	+$636K	0.01%	821
2015 Q3	$510K	Buy	23,814 +15,100	+173%	+$474K	﹤0.01%	1007
2015 Q2	$331K	Sell	8,714 -38	-0.4%	-$1.25K	﹤0.01%	1098
2015 Q1	$274K	Sell	8,752 -2,248	-20%	-$76.2K	﹤0.01%	1124
2014 Q4	$386K	Buy	+11,000	New	+$274K	﹤0.01%	1007

Other funds holding MGNX

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cornerstone Capital Management Holdings's MGNX Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its MacroGenics (MGNX) stake by 25% in Q4 2017, selling an estimated $157K and leaving 25,038 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

Cornerstone Capital Management Holdings first reported a position in MGNX in Q4 2014 and has held it in 13 quarters since. The position peaked at $1.56M in Q3 2016. 119 funds tracked by Wall St. Rank hold MGNX as of Q4 2017.

Cornerstone Capital Management Holdings held 25,038 shares of MacroGenics worth $475K as of Q4 2017.
Cornerstone Capital Management Holdings sold 8,400 MacroGenics shares in Q4 2017, an estimated $157K.
MacroGenics made up ﹤0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #1016 holding.
Cornerstone Capital Management Holdings first reported a position in MacroGenics in Q4 2014 and has held it in 13 quarters since.
Cornerstone Capital Management Holdings's MacroGenics position peaked at $1.56M in Q3 2016.
119 funds tracked by Wall St. Rank held MacroGenics as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.